Orna Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is a biotechnology company reshaping RNA therapeutics. We are developing the leading circular RNA technology platform (oRNA®) and unprecedented lipid nanoparticle (LNP) delivery solutions – unlocking the therapeutic possibilities of circular RNA and pioneering the next chapter of safe and effective in vivo therapies for the treatment of disease. Website: www.ornatx.com
| Website | http://ornatx.com |
| Revenue | $41.2 million |
| Employees | 106 (70 on RocketReach) |
| Founded | 2019 |
| Address | 500 Forge Road 2nd Floor, Watertown, Massachusetts 02742, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Rna Therapeutics, Rna Technology, Biotechnology Platform, Biotechnology, Therapeutics, Drug Delivery, Gene Therapy, Genetic Medicine, Pharmaceutical, Molecular Medicine, Drug Discovery, Biopharma, Precision Medicine, Medicine, Clinical Trials, Healthcare |
| Competitors | Moderna Therapeutics, Zymergen, Inc., RaNA Therapeutics, Sangamo Therapeutics, Inc., Precision BioSciences, Inc., CureVac, AstraZeneca, Vaxart, Inc., Daiichi Sankyo, Inc., Alnylam Pharmaceuticals +30 more (view full list) |
Looking for a particular Orna Therapeutics employee's phone or email?
The Orna Therapeutics annual revenue was $41.2 million in 2026.
Joseph Bolen is the CEO of Orna Therapeutics.
70 people are employed at Orna Therapeutics.
Orna Therapeutics is based in Watertown, Massachusetts.